Reducing Infection in Lower Leg Skin Cancer Wounds

This study is investigating if using special antibacterial washes and ointments before skin cancer surgery on your lower leg can lower your risk of infection. Researchers want to see if applying Chlorhexidine gluconate (a skin wash) and Mupirocin 2% Ointment (an ointment for your nostrils) for five days before surgery helps prevent infections in wounds that are left open to heal. You could be eligible if you are at least 18 years old and are having skin cancer surgery on your lower leg where the wound will be left open. The main goal is to count how many participants get a surgical site infection within one month after their operation. The current status of this study is unclear.

Study design
This is an interventional study planning to enroll 848 participants. It compares a group receiving pre-surgery antibacterial treatment to a group receiving standard care.
What's involved
If you are in the treatment group, you would use a special skin wash daily and an ointment in your nostrils twice daily for 5 days before surgery. You would also send pictures of your wound at 2 and 4 weeks post-operation.
Compensation
Not stated in the trial record.
Follow-up
Participants will be monitored for signs of infection from the date of surgery to one month post-operation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07142408

The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal

Recruiting
PHASE3Ages 18+InterventionalPrevention
The Cooper Health System
~848 participants
Updated 2025-08-26 on ClinicalTrials.gov
What's tested:Chlorhexidine gluconate (4%)Mupirocin 2% Ointment

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of Participants with Surgical Site Wound Infection
Measured over From date of surgery to 1-month post-operation
Surgical Wound Infection

NCT07142408

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • The Center for Dermatologic Surgery at Cooper University Health Care

    Marlton, New Jerseystudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age at least 18 years old
Scheduled to undergo surgical treatment for skin cancer on the lower extremities and have no other surgeries scheduled in the coming weeks after the procedure
Will have a surgical wound that will be left open to heal by secondary intention

Exclusion

Age under 18 years old
Have a known allergy to chlorhexidine or mupirocin
Have a history of Staphylococcus aureus infection
Have a history of heart valve or joint replacement surgery requiring pre-operative antibiotics
  • Number of Participants with Surgical Site Wound InfectionFrom date of surgery to 1-month post-operation

    Signs of infection, including erythema, edema, drainage, and delayed healing, will be visually determined by study physicians with photographs of the surgical site collected from study participants. All patients will be followed up with a phone call at 1 month to monitor for any adverse events and additional signs of infection including pain, tenderness, warmth, and foul odor at the surgical site.